# Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)

> **NCT01553032** · PHASE4 · COMPLETED · sponsor: **University of Heidelberg Medical Center** · enrollment: 139 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Erbitux®
- **RADIATION:** Fractionated Radiotherapy

## Key facts

- **NCT ID:** NCT01553032
- **Lead sponsor:** University of Heidelberg Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2022-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553032, "Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01553032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*